Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 8Phase 1/2 4Phase EARLY_PHASE1 3Phase 1 3Phase 3 2

Status

Completed 5Recruiting 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Sarcoma 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Multiple Myeloma 28Breast Neoplasms 23Neoplasms 21Pancreatic Neoplasms 17Glioma 17Prostatic Neoplasms 16Glioblastoma 16Recurrence 14Leukemia, Myeloid, Acute 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Melanoma 8Lymphoma 8Hematologic Neoplasms 8Lymphoma, B-Cell 7Colorectal Neoplasms 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Advanced Solid Tumors 6Sarcoma 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

Surgical Procedures, Operative 1Sunscreening Agents 1Niacinamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Carcinoma, Basal Cell × Clear all
NCT07286318 2026-06-05

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT07628634 2026-06-05

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

University of California, Irvine

Phase EARLY_PHASE1 Recruiting
25 enrolled
CNSDermatologicGenitourinaryLymphoidSarcoma

Adenocarcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Glioma, Leiomyosarcoma, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Carcinoma, Ductal

NCT07144384 2026-02-13

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
40 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡